January 31, 2015 11:48 PM ET

Capital Markets

Company Overview of EMBL Ventures GmbH

Company Overview

EMBL Ventures GmbH is a venture capital and private equity arm of European Molecular Biology Laboratory specializing in startup, early stage, to later stage investments. The firm prefers to invest in healthcare, biotechnology, medical technology, life-science, therapeutics, enabling technology platforms, pharmaceuticals, diagnostics, and medical devices companies. It seeks to invest in companies based in the European Union. The firm invests between $0.1 million and €30 million ($37.60 million). The firm invests a maximum of €8 million ($10.02 million) in a single portfolio company and it typically considers contributing investment volumes of €3 million ($3.76 million) as part of an investmen...

Boxbergring 107

Heidelberg,  69126

Germany

Founded in 2001

Phone:

49 6221 389330

Fax:

49 6221 3893311

Key Executives for EMBL Ventures GmbH

Founding Partner
Age: 48
Managing Director
Age: 43
Partner
Compensation as of Fiscal Year 2014.

Recent Private Companies Transactions

Type
Date
Target
Private Placement
October 28, 2014
ImevaX GmbH
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EMBL Ventures GmbH, please visit www.embl-ventures.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.